Schiff Andrew F, Deines Danielle, Jensen Elizabeth T, O'Connell Nathaniel, Perry Courtney J, Shaltout Hossam A, Washburn Lisa K, South Andrew M
Department of Pediatrics, Section of Neonatology, Wake Forest University School of Medicine, Winston Salem, NC.
University of Otago School of Medicine, Dunedin, New Zealand.
J Pediatr. 2024 Jan;264:113730. doi: 10.1016/j.jpeds.2023.113730. Epub 2023 Sep 16.
To determine whether greater duration of simultaneous exposure to antimicrobials with high nephrotoxicity risk combined with lower-risk antimicrobials (simultaneous exposure) in the neonatal intensive care unit (NICU) is associated with worse later kidney health in adolescents born preterm with very low birth weight (VLBW).
Prospective cohort study of participants born preterm with VLBW (<1500 g) as singletons between January 1, 1992, and June 30, 1996. We defined simultaneous exposure as a high-risk antimicrobial, such as vancomycin, administered with a lower-risk antimicrobial on the same date in the NICU. Outcomes were serum creatinine, estimated glomerular filtration rate (eGFR), and first-morning urine albumin-creatinine ratio (ACR) at age 14 years. We fit multivariable linear regression models with days of simultaneous exposure and days of nonsimultaneous exposure as main effects, adjusting for gestational age, birth weight, and birth weight z-score.
Of the 147 out of 177 participants who had exposure data, 97% received simultaneous antimicrobials for mean duration 7.2 days (SD 5.6). No participant had eGFR <90 ml/min/1.73 m. The mean ACR was 15.2 mg/g (SD 38.7) and 7% had albuminuria (ACR >30 mg/g). Each day of simultaneous exposure was associated only with a 1.04-mg/g higher ACR (95% CI 1.01 to 1.06).
Despite frequent simultaneous exposure to high-risk combined with lower-risk nephrotoxic antimicrobials in the NICU, there were no clinically relevant associations with worse kidney health identified in adolescence. Although future studies are needed, these findings may provide reassurance in a population thought to be at increased risk of chronic kidney disease.
确定新生儿重症监护病房(NICU)中同时暴露于高肾毒性风险抗菌药物与低风险抗菌药物的时间更长(同时暴露)是否与极低出生体重(VLBW)的早产青少年后期肾脏健康状况较差有关。
对1992年1月1日至1996年6月30日期间出生的单胎VLBW(<1500g)早产儿进行前瞻性队列研究。我们将同时暴露定义为在NICU同一天使用高风险抗菌药物(如万古霉素)与低风险抗菌药物。结局指标为14岁时的血清肌酐、估计肾小球滤过率(eGFR)和晨尿白蛋白肌酐比值(ACR)。我们采用多变量线性回归模型,将同时暴露天数和非同时暴露天数作为主要效应,并对胎龄、出生体重和出生体重Z评分进行调整。
177名参与者中有147名有暴露数据,97%的人同时接受抗菌药物治疗,平均持续时间为7.2天(标准差5.6)。没有参与者的eGFR<90ml/min/1.73m²。平均ACR为15.2mg/g(标准差38.7),7%的人有蛋白尿(ACR>30mg/g)。同时暴露的每一天仅与ACR升高1.04mg/g相关(95%置信区间1.01至1.06)。
尽管在NICU中经常同时暴露于高风险和低风险肾毒性抗菌药物,但未发现与青少年期肾脏健康状况较差存在临床相关关联。尽管需要未来的研究,但这些发现可能会让被认为患慢性肾脏病风险增加的人群感到安心。